- Home
- » Tags
- » Alnespirone
Top View
- Idazoxan and 8-OH-DPAT Modify the Behavioral Effects Induced
- Appendix & Tables
- Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action
- Differential Occupancy of Somatodendritic And
- The Effect of the Selective 5-HT1A Agonists Alnespirone (S-20499
- (12) Patent Application Publication (10) Pub. No.: US 2004/0023948A1 Green Et Al
- 43 Antidepressants Maurizio Fava, MD, and George I
- Pharmaceutical Appendix to the Tariff Schedule 2
- Sleep Apnea and CMV Driver Safety
- Vilazodone for the Treatment of Depression: an Update
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Guaiana, G., Barbui, C., Caldwell, DM, Davies, SJC, Furukawa
- WO 2007/081374 Al
- Full-Text Articles Assessed for Full-Text Articles Excluded, Eligibility (N = 78) (N = 113)
- Pharmaceuticals Appendix
- Somatodendritic 5-HT1A Autoreceptors Mediate The
- Azapirones for the Treatment of Anxiety – an Overview
- Preferential 5-HT1A Autoreceptor Occupancy by Pindolol Is Attenuated in Depressed Patients: Effect of Treatment Or an Endophenotype of Depression?
- Differential Regulation of Somatodendritic Serotonin 5-HT1A
- Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist
- Serotonin-And-Parkinson.Pdf